Fresenius snaps up National Cardiovascular Partners

The dialysis company Fresenius is acquiring National Cardiovascular Partners for an undisclosed amount.

National Cardiovascular Partners works with physicians to create independent outpatient cardiac catheterization and vascular laboratories. According to the company, physicians can retain a majority ownership in the lab.

Fresenius Medical Care specializes in dialysis products and services for treating patients with chronic kidney disease. It has more than 2,150 dialysis facilities in North America and 3,335 dialysis clinics worldwide.

The acquisition will be funded by cash and debt financing. Fresenius expects to generate more than $200 million in revenue in 2015 from the deal.

Candace Stuart, Contributor

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup